GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rangering i aksjer
#3635
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aksjekurs
$27.54
Sist synkronisert: 2026-10-19
Markedsverdi
$4.67B
Endring (1 dag)
-2.73%
Endring (1 år)
-11.86%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Driftsmargin for GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Driftsmargin per October 2026 TTM: 32.54%
Ifølge GlaxoSmithKline Pharmaceuticals Limited sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 32.54%. Ved slutten av 2024 hadde selskapet en driftsmargin på 39.38%.
Historikk for driftsmargin for GlaxoSmithKline Pharmaceuticals Limited fra 2004 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 32.54% | -25.20% |
| 2025 | 43.50% | 10.46% |
| 2024 | 39.38% | 69.60% |
| 2023 | 23.22% | 8.10% |
| 2022 | 21.48% | 19.27% |
| 2021 | 18.01% | 6.88% |
| 2020 | 16.85% | -19.30% |
| 2019 | 20.88% | 14.22% |
| 2018 | 18.28% | 35.41% |
| 2017 | 13.50% | -19.59% |
| 2016 | 16.79% | -9.34% |
| 2015 | 18.52% | -8.95% |
| 2013 | 20.34% | -32.47% |
| 2012 | 30.12% | -22.75% |
| 2011 | 38.99% | -3.78% |
| 2010 | 40.52% | 1.55% |
| 2009 | 39.90% | -3.62% |
| 2008 | 41.40% | 6.10% |
| 2007 | 39.02% | 8.99% |
| 2006 | 35.80% | 11.32% |
| 2005 | 32.16% | 5.96% |
| 2004 | 30.35% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 49.72% | -98.47% |
US
|
|
| 25.70% | -99.21% |
US
|
|
| 29.32% | -99.10% |
US
|
|
| 16.65% | -99.49% |
US
|
|
| 26.59% | -99.18% |
CH
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.